Predictors of 7- and 30-day mortality in pediatric intensive care unit patients with cancer and hematologic malignancy infected with Gram-negative bacteria

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 6, 2014, Pages 591-599

  De Oliveira Costa, Patrícia ^a   Atta, Elias Hallack ^a   da Silva, André Ricardo Araujo ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Cancer; Infection with Gram negative bacteria; Mortality; Pediatric intensive care unit

Indexed keywords

ANTIINFECTIVE AGENT; CORTICOSTEROID;

ACINETOBACTER BAUMANNII; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM TUMOR; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GRAM NEGATIVE INFECTION; HEALTHCARE ASSOCIATED INFECTION; HEMATOLOGIC MALIGNANCY; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIDRUG RESISTANCE; NEUROBLASTOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PREDICTION; PSEUDOMONAS; PSEUDOMONAS INFECTION; RETINOBLASTOMA; RHABDOMYOSARCOMA; RISK FACTOR; SEX DIFFERENCE; SOLID TUMOR; SURVIVAL RATE; THROAT CULTURE; TREATMENT DURATION; ADOLESCENT; HEMATOLOGIC DISEASE; IMMUNOCOMPROMISED PATIENT; MICROBIOLOGY; MORTALITY; NEOPLASM; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; TIME;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HOSPITAL MORTALITY; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; NEOPLASMS; RISK FACTORS; TIME FACTORS;

EID: 84926129038     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2014.05.012     Document Type: Article

References (21)

1. Phillips R.S., Sutton A.J., Riley R.D., et al. Predicting infectious complications in neutropenic and young people with cancer (IPD protocol). Syst Rev 2012, 1:8.
2. Turkoglu M., Mirza E., Tunçcan O.G., et al. Acientobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality. J Crit Care 2011, 26:460-467.
3. Rosolem M.M., Rabello L.S., Lisboa T., et al. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care 2012, 27:301-307.
4. Tantaleán J.A., León R.J., Santos A.A., Sanchez E. Multiple organ dysfunction syndrome in children. Pediatr Crit Care Med 2003, 4:181-185.
5. Tabah A., Koulenti D., Laupland K., et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med 2012, 38:1930-1945.
6. Haeusler G.M., Mechinaud F., Daley A., et al. Antibiotic resistant gram-negative bacteremia in pediatric oncology patients - risk factors and outcome. Pediatr Infect Dis J 2013, 32:723-726.
7. Demiraslan H., Sevim M., Pala Ç., et al. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol 2013, 97:414-420.
8. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596.
9. Rodrígues-Baño J., Picón E., Gijón P., et al. Risk factors for and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. J Clin Microbiol 2010, 48:1726-1731.
10. Kang C.I., Kim S.H., Kim D.M., et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004, 25:860-867.
11. To K.K., Lo W.U., Chan J.F., et al. Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity. Int J Infect Dis 2013, 17:e120-e124.
12. Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriacea-EUCAST and CLSI breakpoints. Clin Microbiol Infect 2008, 14:169-174.
13. Paterson D.L., Ko W.C., Von Gottberg A., et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001, 39:2206-2212.
14. Corona A., Bertolini G., Lipman J., Wilson A.P., Singer M. Antibiotic use and impact on outcome from bacteremia critical illness: the BActeraemia Study in Intensive Care (BASIC). J Antimicrob Chemother 2010, 65:1276-1285.
15. Razazi K., Derde L.P., Verachten M., Legrand P., Lesprit P., Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012, 38:1769-1778.
16. Tan R., Liu J., Li M., et al. Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai. J Microbiol Immunol Infect 2014, 47:87-94.
17. Corbella X., Pujol M., Ayats J., et al. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 1996, 23:329-334.
18. Harris A.D., McGregor J.C., Johnson J.A., et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007, 13:1144-1149.
19. Balkhy H.H., Bawazeer M.S., Kattan R.F., et al. Epidemiology of Acinetobacter spp.-associated healthcare infections and colonization among children at a tertiary-care hospital in Saudi Arabia: a 6-year retrospective cohort study. Eur J Clin Microbiol Infect Dis 2012, 31:2645-2651.
20. Blot S., Depuydt P., Vogelaers D., et al. Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit. Infect Control Hosp Epidemiol 2005, 26:575-579.
21. Nemeth J., Ledergerber B., Preiswerk B., et al. Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome. J Hosp Infect 2012, 82:254-259.